🇺🇸 AMRX — Amneal Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

20,21 USD

Máx. histórico

24,27

2997 días

Caída desde máximo

-16,73%

Rango 52 semanas

10,92 – 21,68

Variación hoy

-1,13%

Cierre anterior

20,44

Rango de hoy

19,68 – 20,81

Volumen hoy

6.439.530

Peor caída histórica

-94,77%

20/08/2018 → 28/03/2023

Aún sin recuperar

Volatilidad anualizada ⓘ

63,13%

Información
Nombre completo
Amneal Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
8.700
PER ⓘ
41,24 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
23,43 USD (puede no estar actualizado)
Primera cotización
07/05/2018
Precio actualizado
hace 17 horas
Sobre la empresa

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with a focus on central nervous system and endocrine disorders, including Parkinson's disease. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT, which is use for the treatment of Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 5,52 5,91 5,48 5,91 +7,45% 7,79% 2.002.900
15/03/2024 5,36 5,52 5,35 5,50 +2,04% 3,17% 2.240.200
14/03/2024 5,37 5,40 5,25 5,39 -0,19% 2,79% 1.059.100
13/03/2024 5,32 5,47 5,26 5,40 +1,69% 3,85% 867.800
12/03/2024 5,40 5,48 5,28 5,31 -1,30% 3,70% 1.073.000
11/03/2024 5,39 5,49 5,36 5,38 -0,19% 2,32% 967.500
08/03/2024 5,29 5,52 5,29 5,39 +1,51% 4,35% 1.112.000
07/03/2024 5,32 5,37 5,25 5,31 +0,00% 2,26% 929.400
06/03/2024 5,34 5,39 5,21 5,31 -0,56% 3,37% 1.135.000
05/03/2024 5,40 5,45 5,32 5,34 -1,11% 2,41% 936.100
04/03/2024 5,43 5,51 5,31 5,40 -1,28% 3,78% 1.627.200
01/03/2024 6,12 6,15 5,01 5,47 -0,91% 18,63% 5.961.600
29/02/2024 5,55 5,62 5,36 5,52 +0,00% 4,68% 3.380.900
28/02/2024 5,63 5,66 5,48 5,52 -3,33% 3,20% 1.800.700
27/02/2024 5,71 5,81 5,36 5,71 -1,89% 7,88% 2.153.400
26/02/2024 5,84 5,92 5,67 5,82 +0,34% 4,37% 1.440.400
23/02/2024 5,70 5,81 5,61 5,80 +1,93% 3,51% 688.500
22/02/2024 5,80 5,91 5,67 5,69 -0,70% 4,14% 945.300
21/02/2024 5,74 5,84 5,65 5,73 -0,87% 3,22% 831.000
20/02/2024 5,81 5,87 5,75 5,78 -2,03% 2,07% 1.221.000
16/02/2024 5,82 5,93 5,74 5,90 +0,17% 3,26% 1.154.800
15/02/2024 5,88 6,09 5,87 5,89 +1,20% 3,66% 1.397.800
14/02/2024 5,71 5,87 5,67 5,82 +3,93% 3,50% 991.500
13/02/2024 5,63 5,77 5,42 5,60 -4,27% 6,22% 1.316.800
12/02/2024 5,54 5,87 5,53 5,85 +5,03% 6,14% 1.896.600
09/02/2024 5,47 5,57 5,41 5,57 +2,01% 2,93% 966.400
08/02/2024 5,30 5,51 5,29 5,46 +1,87% 4,09% 972.600
07/02/2024 5,60 5,60 5,35 5,36 -4,29% 4,46% 969.900
06/02/2024 5,50 5,67 5,48 5,60 +1,45% 3,36% 914.300
05/02/2024 5,45 5,57 5,43 5,52 +0,00% 2,48% 915.500